Earnings Feed
Start Free
$PVCT·4

PROVECTUS BIOPHARMACEUTICALS, INC. · Jan 7, 3:29 PM ET

PROVECTUS BIOPHARMACEUTICALS, INC. 4

4 · PROVECTUS BIOPHARMACEUTICALS, INC. · Filed Jan 7, 2015

Insider Transaction Report

Form 4
Period: 2015-01-07
PROVECTUS BIOPHARMACEUTICALS, INC.PVCT
CULPEPPER PETER R
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2015-01-07$0.75/sh+33,334$25,001→ 154,334 total(indirect: By 401(k))
  • Exercise/Conversion

    Common Stock

    2015-01-07$0.94/sh+29,786$27,999→ 184,120 total(indirect: By 401(k))
  • Exercise/Conversion

    Stock Option (right to buy)

    2015-01-07−33,334→ 0 total
    Exercise: $0.75Exp: 2015-05-25→ Common Stock (33,334 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2015-01-07−29,786→ 145,214 total
    Exercise: $0.94Exp: 2015-12-09→ Common Stock (29,786 underlying)
Holdings

  • Common Stock

    1,112,332
Footnotes (2)
  • [F1]The option became exercisable in three equal annual installments beginning on May 26, 2006.
  • [F2]The option became exercisable in three equal annual installments beginning on December 9, 2006.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4